Lazard Asset Management’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-38
| Closed | – | – | 2288 |
|
|
2024
Q3 | $0 | Sell |
38
-3,867
| -99% | – | ﹤0.01% | 2269 |
|
|
2024
Q2 | $98K | Buy |
+3,905
| New | +$98K | ﹤0.01% | 1754 |
|
|
2023
Q2 | – | Sell |
-12,292
| Closed | -$203K | – | 2304 |
|
|
2023
Q1 | $203K | Sell |
12,292
-63,309
| -84% | -$1.05M | ﹤0.01% | 1310 |
|
|
2022
Q4 | $576K | Sell |
75,601
-24,076
| -24% | -$183K | ﹤0.01% | 1096 |
|
|
2022
Q3 | $990K | Buy |
99,677
+74,255
| +292% | +$738K | ﹤0.01% | 990 |
|
|
2022
Q2 | $230K | Sell |
25,422
-6,455
| -20% | -$58.4K | ﹤0.01% | 1241 |
|
|
2022
Q1 | $323K | Buy |
31,877
+12,870
| +68% | +$130K | ﹤0.01% | 1177 |
|
|
2021
Q4 | $317K | Buy |
19,007
+18,025
| +1,836% | +$301K | ﹤0.01% | 1188 |
|
|
2021
Q3 | $46K | Buy |
+982
| New | +$46K | ﹤0.01% | 1714 |
|
|
2021
Q1 | – | Sell |
-6,726
| Closed | -$478K | – | 1856 |
|
|
2020
Q4 | $478K | Buy |
+6,726
| New | +$478K | ﹤0.01% | 981 |
|